Reports for BAUSCH HEALTH, CANADA INC.
Company Name
BAUSCH HEALTH, CANADA INC.
Totals |
||
Shortage reports |
348 |
|
| Actual shortage: | 10 (3%) | |
| Anticipated shortage: | 1 (0%) | |
| Avoided shortage: | 34 (10%) | |
| Resolved: | 303 (87%) | |
Discontinuation Reports |
13 |
|
| To be discontinued: | 1 (8%) | |
| Discontinued: | 12 (92%) | |
| Reversed: | 0 (0%) | |
Late reports |
96 (27%) |
|
Overdue reports |
1 (8%) |
|
Shortage reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| DELATESTRYL | 200MG | SOLUTION | Resolved | 2021-02-26 | 2021-09-13 | 134792 |
| DELATESTRYL | 200MG | SOLUTION | Resolved | 2022-12-02 | 2022-12-21 | 176956 |
| DELATESTRYL | 200MG | SOLUTION | Resolved | 2023-01-18 | 2023-04-22 | 181436 |
| DELATESTRYL | 200MG | SOLUTION | Resolved | 2023-05-04 | 2023-05-31 | 191622 |
| DELATESTRYL | 200MG | SOLUTION | Resolved | 2023-09-28 | 2023-10-26 | 205404 |
| DELATESTRYL | 200MG | SOLUTION | Resolved | 2024-01-22 | 2024-02-01 | 216889 |
| RALIVIA | 200MG | TABLET (EXTENDED-RELEASE) | Resolved | 2017-09-15 | 2017-09-25 | 22155 |
| RALIVIA | 200MG | TABLET (EXTENDED-RELEASE) | Resolved | 2022-04-07 | 2022-06-02 | 158236 |
| TIAZAC XC | 240MG | TABLET (EXTENDED-RELEASE) | Avoided shortage | 2019-09-10 | 2019-09-13 | 93532 |
| ALTACE HCT | 25.0MG 10.0MG | TABLET | Resolved | 2017-08-17 | 2017-09-07 | 19730 |
| ALTACE HCT | 25.0MG 10.0MG | TABLET | Resolved | 2019-12-11 | 2020-05-13 | 101030 |
| ALTACE HCT | 25.0MG 5.0MG | TABLET | Resolved | 2017-05-26 | 2017-09-02 | 11351 |
| ALTACE HCT | 25.0MG 5.0MG | TABLET | Resolved | 2017-10-20 | 2018-03-17 | 26483 |
| ALTACE HCT | 25.0MG 5.0MG | TABLET | Resolved | 2018-05-11 | 2018-06-09 | 49074 |
| ALTACE HCT | 25.0MG 5.0MG | TABLET | Resolved | 2020-02-14 | 2020-10-28 | 106252 |
| CUPRIMINE | 250mg | Capsule | Resolved | 2017-03-14 | 2017-08-17 | 2263 |
| CUPRIMINE | 250MG | CAPSULE | Resolved | 2018-09-18 | 2018-12-22 | 61800 |
| CUPRIMINE | 250MG | CAPSULE | Resolved | 2022-08-03 | 2022-09-01 | 166020 |
| CUPRIMINE | 250MG | CAPSULE | Avoided shortage | 2023-03-13 | 2023-03-23 | 186886 |
| CUPRIMINE | 250MG | CAPSULE | Resolved | 2023-05-11 | 2023-07-10 | 192293 |
Discontinuation reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| VITAMIN A ACID | 0.01% | GEL | To be discontinued | 2024-01-30 | 2024-01-30 | 217835 |
| VITAMIN A ACID | 0.025% | GEL | Discontinued | 2024-01-30 | 2024-02-08 | 217848 |
| VITAMIN A ACID | 0.05% | GEL | Discontinued | 2024-01-30 | 2024-02-08 | 217843 |
| LIDEX | 0.05% | CREAM | Discontinued | 2023-12-08 | 2023-12-08 | 212804 |
| AIROMIR | 100MCG | METERED-DOSE AEROSOL | Discontinued | 2023-11-29 | 2023-11-29 | 211859 |
| ALTACE HCT | 12.5MG 10MG | TABLET | Discontinued | 2023-12-21 | 2024-01-09 | 214024 |
| ALTACE HCT | 12.5MG 2.5MG | TABLET | Discontinued | 2023-12-21 | 2024-01-09 | 214011 |
| ALTACE HCT | 12.5MG 5MG | TABLET | Discontinued | 2023-12-21 | 2024-01-09 | 214014 |
| DELATESTRYL | 200MG | SOLUTION | Discontinued | 2024-03-11 | 2024-04-26 | 221772 |
| ALTACE HCT | 25MG 10MG | TABLET | Discontinued | 2023-12-21 | 2024-01-09 | 214027 |
| ALTACE HCT | 25MG 5MG | TABLET | Discontinued | 2023-12-21 | 2024-01-09 | 214017 |
| LODALIS | 3.75G | POWDER FOR SUSPENSION | Discontinued | 2023-12-08 | 2024-02-20 | 212799 |
| THEOLAIR | 80MG | SOLUTION | Discontinued | 2021-04-26 | 2021-04-27 | 138081 |
Showing 1 to 13 of 13